COVID-19 News & Media

News and Information on COVID-19

Latest COVID-19 News

Sep 8 2020

LabCorp Launches First Combined Test for COVID-19, Flu and RSV in Time for Flu Season

Single Test Detects Multiple Respiratory Infections Including COVID-19 and Flu to Inform Treatment Options

At-Home Use Through Pixel by LabCorp™ Pending FDA Authorization

BURLINGTON, N.C. - LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced the launch of the first testing method to simultaneously detect COVID-19, influenza A / B, and respiratory syncytial virus (RSV). The single-panel test, which detects multiple types of infections, can help doctors diagnose patients and make decisions about treatment options. The test is available to patients through doctors, hospitals, and other authorized healthcare providers nationwide. LabCorp has also submitted an application to the U.S. Food and Drug Administration (FDA) to offer the combined test through its Pixel by LabCorp™ at-home test collection kit, which would offer added convenience and accessibility.

Read more »

Testing Overview

14.8M

Molecular 
tests performed

200K

Molecular test 
capacity per day**

>2.8M

Antibody
tests performed

300K

Antibody test 
capacity per day**

Tests Offered with No Upfront Costs
by LabCorp*

LabCorp's COVID-19 PCR Testing
Average Time to Result+

1 Day

Week ending September 20, 2020

Previous News Releases and Media Statements

Get COVID-19 Updates from LabCorp

Sign up to receive COVID-19 testing updates and other relevant messages from LabCorp.

Scroll back to top of page